Anti-viral compounds
Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
AbbVie Inc.
C C A C C C C A C A A C C C A C C A C C C C
C07C C07D A61P C07C C07K C07D C07F A61P C07D A61P A61P C07C C07D C07D A61P C07D C07D A61P C07D C07D C07D C07D
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Douglas K. Mary E. David A. David A. Warren M. Rolf Wenke Michael D. John K. Todd W. Pamela L. Kevin R. Christopher E. Jean C. Yi Kathy Charles W. Tammie K. Lissa T. Seble H. Ryan G. Clarence J. Daniel D. Mark A. Sachin V. John T. Charles A. Allan C. Dachun
Hutchinson Bellizzi DeGoey Betebenner Kati Wagner Li Tufano Pratt Rockway Donner Woller Motter Califano Gao Sarris Hutchins Jinkerson Nelson Wagaw Keddy Maring Caspi Matulenko Patel Randolph Flentge Krueger Liu